Katharine O'Banion
Lawyers
Filters
SoftBank $20 billion monetization of its T-Mobile shareholdings
As part of the transaction, T-Mobile used proceeds from a new $16 billion stock offering to purchase its shares from SoftBank
Under Armour $440 million convertible senior notes offering
Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by Under Armour, Inc. of $440 million aggregate principal amount of its 1.500%…
Plug Power $200 million convertible senior notes offering
Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A offering by Plug Power Inc. of $200 million aggregate principal amount of its 3.750%…
Cree $575 million convertible senior notes offering
Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by Cree, Inc. of $575 million aggregate principal amount of its 1.750% convertible…
Coherus BioSciences $200 million convertible notes offering
Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by Coherus BioSciences, Inc. of $200 million aggregate principal amount of its…
Sea Limited $1.15 Billion Convertible Senior Notes Offering
Davis Polk advised the initial purchaser in connection with a Rule 144A and Regulation S offering by Sea Limited of $1.15 billion aggregate principal amount of its 1.00% convertible senior…
Insulet Corporation Convertible Senior Notes Offering
Davis Polk advised the initial purchasers in connection with a Rule 144A offering by Insulet Corporation of $800 million principal amount of 0.375% convertible senior notes due 2026,…
Coupa Software $805 Million Convertible Senior Notes Offering
Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by Coupa Software Incorporated of $805 million aggregate principal amount of its 0…
Intercept Pharmaceuticals, Inc. Concurrent $231 Million Common Stock Offering and $230 Million Convertible Senior Notes Offering
Davis Polk advised the representatives of the several underwriters in connection with the SEC-registered offering of 2,760,000 shares of common stock of Intercept Pharmaceuticals, Inc. …
8x8, Inc. $287.5 Million Convertible Senior Notes Offering
Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A offering by 8x8, Inc. of $287.5 million aggregate principal amount of its 0.50% convertible…